nasdaq-mynz-mainzbiomed.png
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
05 mars 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
nasdaq-mynz-mainzbiomed.png
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
27 févr. 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
22 févr. 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
21 févr. 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
06 févr. 2024 08h01 HE | Mainz BioMed NV
MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY
nasdaq-mynz-mainzbiomed.png
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
11 janv. 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Provides Year-End Corporate Review 2023
09 janv. 2024 08h01 HE | Mainz BioMed NV
Mainz Biomed Provides Year-End Corporate Review 2023
nasdaq-mynz-mainzbiomed.png
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
19 déc. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
12 déc. 2023 08h01 HE | Mainz BioMed NV
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
nasdaq-mynz-mainzbiomed.png
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
05 déc. 2023 09h01 HE | Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers